Prophylactic Human Vaccine Market Report

China Prophylactic Human Vaccine Industry Market Research Report 2023-2029

  • POSTDATE：Sep 04, 2023
  • PAGES：152
  • REPORT CODE：GMM1777024
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Prophylactic Human Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck

    • Biovac

    • Novavax

    • Sanofi

    • Inovio Pharmaceuticals

    • McKesson Medical

    • Zoetis

    • Merial

    • Emergent BioSolutions

    By Type:

    • Inactivated Vaccine

    • Others

    • Attenuated Vaccine

    By Application:

    • Rabies

    • Tetanus

    • Influenza

    • Cholera

    • Chicken pox

    • Poliomyelitis

    • Anthrax

    • Tuberculosis

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Prophylactic Human Vaccine Market Overview 2018-2029

    • 1.1 China Prophylactic Human Vaccine Industry Development Overview

    • 1.2 China Prophylactic Human Vaccine Industry Development History

    • 1.3 China Prophylactic Human Vaccine Industry Market Size (2018-2029)

    • 1.4 China Prophylactic Human Vaccine Market Analysis by Type from Production Side

      • 1.4.1 China Prophylactic Human Vaccine Production Volume, Production Value and Growth Rate of Inactivated Vaccine (2018-2029)

      • 1.4.2 China Prophylactic Human Vaccine Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Prophylactic Human Vaccine Production Volume, Production Value and Growth Rate of Attenuated Vaccine (2018-2029)

    • 1.5 China Prophylactic Human Vaccine Market Analysis by Application from Consumption End

      • 1.5.1 China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Rabies (2018-2029)

      • 1.5.2 China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Tetanus (2018-2029)

      • 1.5.3 China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Influenza (2018-2029)

      • 1.5.4 China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Cholera (2018-2029)

      • 1.5.5 China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Chicken pox (2018-2029)

      • 1.5.6 China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Poliomyelitis (2018-2029)

      • 1.5.7 China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Anthrax (2018-2029)

      • 1.5.8 China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Tuberculosis (2018-2029)

    • 1.6 China Prophylactic Human Vaccine Market Analysis by Region

      • 1.6.1 North China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

    Chapter 2 China Prophylactic Human Vaccine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Prophylactic Human Vaccine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Prophylactic Human Vaccine Market Status and Competition Analysis in 2023

      • 2.2.3 China Prophylactic Human Vaccine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Prophylactic Human Vaccine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Prophylactic Human Vaccine Industry Development

    Chapter 3 Prophylactic Human VaccineIndustry Chain Analysis

    • 3.1 Prophylactic Human Vaccine Industry Chain

    • 3.2 Prophylactic Human Vaccine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Prophylactic Human Vaccine Market

    • 3.3 Prophylactic Human Vaccine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Prophylactic Human Vaccine Market

    Chapter 4 China Prophylactic Human Vaccine Market, by Type

    • 4.1 China Prophylactic Human Vaccine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Prophylactic Human Vaccine Total Production Volume and Growth Rate from Production Side

    • 4.5 China Prophylactic Human Vaccine Production Volume and Growth Rate, by Type

      • 4.5.1 China Prophylactic Human Vaccine Production Volume and Growth Rate of Inactivated Vaccine

      • 4.5.2 China Prophylactic Human Vaccine Production Volume and Growth Rate of Others

      • 4.5.3 China Prophylactic Human Vaccine Production Volume and Growth Rate of Attenuated Vaccine

    Chapter 5 China Prophylactic Human Vaccine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Prophylactic Human Vaccine Total Market Size and Growth Rate from Consumption End

    • 5.5 China Prophylactic Human Vaccine Market Size and Growth Rate, by Application

      • 5.5.1 China Prophylactic Human Vaccine Market Size and Growth Rate of Rabies

      • 5.5.2 China Prophylactic Human Vaccine Market Size and Growth Rate of Tetanus

      • 5.5.3 China Prophylactic Human Vaccine Market Size and Growth Rate of Influenza

      • 5.5.4 China Prophylactic Human Vaccine Market Size and Growth Rate of Cholera

      • 5.5.5 China Prophylactic Human Vaccine Market Size and Growth Rate of Chicken pox

      • 5.5.6 China Prophylactic Human Vaccine Market Size and Growth Rate of Poliomyelitis

      • 5.5.7 China Prophylactic Human Vaccine Market Size and Growth Rate of Anthrax

      • 5.5.8 China Prophylactic Human Vaccine Market Size and Growth Rate of Tuberculosis

    Chapter 6 China Prophylactic Human Vaccine Market, by Region

    • 6.1 China Prophylactic Human Vaccine Production Volume and Production Value, by Region

    • 6.2 China Prophylactic Human Vaccine Sales Volume and Sales Value, by Region

    Chapter 7 North China Prophylactic Human Vaccine Market Analysis

    • 7.1 North China Prophylactic Human Vaccine Market, by Type

    • 7.2 North China Prophylactic Human Vaccine Market, by Application

    Chapter 8 Central China Prophylactic Human Vaccine Market Analysis

    • 8.1 Central China Prophylactic Human Vaccine Market, by Type

    • 8.2 Central China Prophylactic Human Vaccine Market, by Application

    Chapter 9 South China Prophylactic Human Vaccine Market Analysis

    • 9.1 South China Prophylactic Human Vaccine Market, by Type

    • 9.2 South China Prophylactic Human Vaccine Market, by Application

    Chapter 10 East China Prophylactic Human Vaccine Market Analysis

    • 10.1 East China Prophylactic Human Vaccine Market, by Type

    • 10.2 East China Prophylactic Human Vaccine Market, by Application

    Chapter 11 Northeast China Prophylactic Human Vaccine Market Analysis

    • 11.1 Northeast China Prophylactic Human Vaccine Market, by Type

    • 11.2 Northeast China Prophylactic Human Vaccine Market, by Application

    Chapter 12 Southwest China Prophylactic Human Vaccine Market Analysis

    • 12.1 Southwest China Prophylactic Human Vaccine Market, by Type

    • 12.2 Southwest China Prophylactic Human Vaccine Market, by Application

    Chapter 13 Northwest China Prophylactic Human Vaccine Market Analysis

    • 13.1 Northwest China Prophylactic Human Vaccine Market, by Type

    • 13.2 Northwest China Prophylactic Human Vaccine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck

        • 14.1.1 Merck Company Profile

        • 14.1.2 Merck Prophylactic Human Vaccine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Biovac

        • 14.2.1 Biovac Company Profile

        • 14.2.2 Biovac Prophylactic Human Vaccine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Novavax

        • 14.3.1 Novavax Company Profile

        • 14.3.2 Novavax Prophylactic Human Vaccine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sanofi

        • 14.4.1 Sanofi Company Profile

        • 14.4.2 Sanofi Prophylactic Human Vaccine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Inovio Pharmaceuticals

        • 14.5.1 Inovio Pharmaceuticals Company Profile

        • 14.5.2 Inovio Pharmaceuticals Prophylactic Human Vaccine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 McKesson Medical

        • 14.6.1 McKesson Medical Company Profile

        • 14.6.2 McKesson Medical Prophylactic Human Vaccine Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Zoetis

        • 14.7.1 Zoetis Company Profile

        • 14.7.2 Zoetis Prophylactic Human Vaccine Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merial

        • 14.8.1 Merial Company Profile

        • 14.8.2 Merial Prophylactic Human Vaccine Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Emergent BioSolutions

        • 14.9.1 Emergent BioSolutions Company Profile

        • 14.9.2 Emergent BioSolutions Prophylactic Human Vaccine Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Prophylactic Human Vaccine Industry Research Conclusions

    • 15.2 Prophylactic Human Vaccine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Prophylactic Human Vaccine Industry Market Size (2018-2029)

    • Figure China Prophylactic Human Vaccine Production Volume, Production Value and Growth Rate of Inactivated Vaccine (2018-2029)

    • Figure China Prophylactic Human Vaccine Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Prophylactic Human Vaccine Production Volume, Production Value and Growth Rate of Attenuated Vaccine (2018-2029)

    • Figure China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Rabies (2018-2029)

    • Figure China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Tetanus (2018-2029)

    • Figure China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Influenza (2018-2029)

    • Figure China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Cholera (2018-2029)

    • Figure China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Chicken pox (2018-2029)

    • Figure China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Poliomyelitis (2018-2029)

    • Figure China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Anthrax (2018-2029)

    • Figure China Prophylactic Human Vaccine Sales Volume, Sales Value and Growth Rate of Tuberculosis (2018-2029)

    • Figure North China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Central China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

    • Figure South China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

    • Figure East China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Prophylactic Human Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Prophylactic Human Vaccine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Prophylactic Human Vaccine Market Share by Type in 2018

    • Figure China Prophylactic Human Vaccine Market Share by Type in 2023

    • Figure China Prophylactic Human Vaccine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Prophylactic Human Vaccine Production Volume and Growth Rate of Inactivated Vaccine (2018-2023)

    • Figure China Prophylactic Human Vaccine Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Prophylactic Human Vaccine Production Volume and Growth Rate of Attenuated Vaccine (2018-2023)

    • Figure China Prophylactic Human Vaccine Market Share by Application in 2018

    • Figure China Prophylactic Human Vaccine Market Share by Application in 2023

    • Figure China Prophylactic Human Vaccine Total Market Size and Growth Rate from Consumption End

    • Figure China Prophylactic Human Vaccine Market Size and Growth Rate of Rabies (2018-2023)

    • Figure China Prophylactic Human Vaccine Market Size and Growth Rate of Tetanus (2018-2023)

    • Figure China Prophylactic Human Vaccine Market Size and Growth Rate of Influenza (2018-2023)

    • Figure China Prophylactic Human Vaccine Market Size and Growth Rate of Cholera (2018-2023)

    • Figure China Prophylactic Human Vaccine Market Size and Growth Rate of Chicken pox (2018-2023)

    • Figure China Prophylactic Human Vaccine Market Size and Growth Rate of Poliomyelitis (2018-2023)

    • Figure China Prophylactic Human Vaccine Market Size and Growth Rate of Anthrax (2018-2023)

    • Figure China Prophylactic Human Vaccine Market Size and Growth Rate of Tuberculosis (2018-2023)

    • Table China Prophylactic Human Vaccine Production Volume by Region (2018-2023)

    • Table China Prophylactic Human Vaccine Production Volume Share by Region (2018-2023)

    • Figure China Prophylactic Human Vaccine Production Volume Share by Region (2018-2023)

    • Table China Prophylactic Human Vaccine Production Value by Region (2018-2023)

    • Table China Prophylactic Human Vaccine Production Value Share by Region (2018-2023)

    • Figure China Prophylactic Human Vaccine Production Value Share by Region (2018-2023)

    • Table China Prophylactic Human Vaccine Sales Volume by Region (2018-2023)

    • Table China Prophylactic Human Vaccine Sales Volume Share by Region (2018-2023)

    • Figure China Prophylactic Human Vaccine Sales Volume Share by Region (2018-2023)

    • Table China Prophylactic Human Vaccine Sales Value by Region (2018-2023)

    • Table China Prophylactic Human Vaccine Sales Value Share by Region (2018-2023)

    • Figure China Prophylactic Human Vaccine Sales Value Share by Region (2018-2023)

    • Table North China Prophylactic Human Vaccine Production Volume by Type (2018-2023)

    • Table North China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Figure North China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Table North China Prophylactic Human Vaccine Sales Volume by Application (2018-2023)

    • Table North China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Figure North China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Table Central China Prophylactic Human Vaccine Production Volume by Type (2018-2023)

    • Table Central China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Figure Central China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Table Central China Prophylactic Human Vaccine Sales Volume by Application (2018-2023)

    • Table Central China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Central China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Table South China Prophylactic Human Vaccine Production Volume by Type (2018-2023)

    • Table South China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Figure South China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Table South China Prophylactic Human Vaccine Sales Volume by Application (2018-2023)

    • Table South China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Figure South China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Table East China Prophylactic Human Vaccine Production Volume by Type (2018-2023)

    • Table East China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Figure East China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Table East China Prophylactic Human Vaccine Sales Volume by Application (2018-2023)

    • Table East China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Figure East China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northeast China Prophylactic Human Vaccine Production Volume by Type (2018-2023)

    • Table Northeast China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northeast China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Table Northeast China Prophylactic Human Vaccine Sales Volume by Application (2018-2023)

    • Table Northeast China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Table Southwest China Prophylactic Human Vaccine Production Volume by Type (2018-2023)

    • Table Southwest China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Figure Southwest China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Table Southwest China Prophylactic Human Vaccine Sales Volume by Application (2018-2023)

    • Table Southwest China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northwest China Prophylactic Human Vaccine Production Volume by Type (2018-2023)

    • Table Northwest China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northwest China Prophylactic Human Vaccine Production Volume Share by Type (2018-2023)

    • Table Northwest China Prophylactic Human Vaccine Sales Volume by Application (2018-2023)

    • Table Northwest China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Prophylactic Human Vaccine Sales Volume Share by Application (2018-2023)

    • Table Merck Company Profile

    • Table Merck Prophylactic Human Vaccine Revenue, Price and Gross (2018-2023)

    • Table Biovac Company Profile

    • Table Biovac Prophylactic Human Vaccine Revenue, Price and Gross (2018-2023)

    • Table Novavax Company Profile

    • Table Novavax Prophylactic Human Vaccine Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Prophylactic Human Vaccine Revenue, Price and Gross (2018-2023)

    • Table Inovio Pharmaceuticals Company Profile

    • Table Inovio Pharmaceuticals Prophylactic Human Vaccine Revenue, Price and Gross (2018-2023)

    • Table McKesson Medical Company Profile

    • Table McKesson Medical Prophylactic Human Vaccine Revenue, Price and Gross (2018-2023)

    • Table Zoetis Company Profile

    • Table Zoetis Prophylactic Human Vaccine Revenue, Price and Gross (2018-2023)

    • Table Merial Company Profile

    • Table Merial Prophylactic Human Vaccine Revenue, Price and Gross (2018-2023)

    • Table Emergent BioSolutions Company Profile

    • Table Emergent BioSolutions Prophylactic Human Vaccine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US